{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:05:16Z","timestamp":1792821916175,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273468"],"award-info":[{"award-number":["81273468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473153"],"award-info":[{"award-number":["81473153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2015CB755500"],"award-info":[{"award-number":["2015CB755500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province of China","doi-asserted-by":"publisher","award":["BK20140672"],"award-info":[{"award-number":["BK20140672"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central Universities of China","award":["0201000144"],"award-info":[{"award-number":["0201000144"]}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["SKLNMZZCX201401"],"award-info":[{"award-number":["SKLNMZZCX201401"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State Administration of Foreign Expert Affairs of China","award":["111-2-07"],"award-info":[{"award-number":["111-2-07"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.biomaterials.2015.09.022","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T02:00:14Z","timestamp":1442368814000},"page":"284-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"special_numbering":"C","title":["Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment"],"prefix":"10.1016","volume":"73","author":[{"given":"Assogba G.","family":"Assanhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2015.09.022_bib1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0344-0338(96)80099-9","article-title":"Molecular mechanisms of multidrug resistance in cancer chemotherapy","volume":"192","author":"Nooter","year":"1996","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.cgt.7700751","article-title":"Stable and complete overcoming of MDR1\/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference","volume":"11","author":"Stege","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer","volume":"46","author":"Baguley","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib5","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/sj.onc.1206950","article-title":"Transcriptional regulation of ABC drug transporters","volume":"22","author":"Scotto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib7","first-page":"51","article-title":"Selecting surfactants for the maximum inhibition of the activity of the multidrug resistance efflux pump transporter, P-glycoprotein: conceptual development","volume":"1","author":"Prakash","year":"2010","journal-title":"J.\u00a0Excip. Food Chem."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11095-007-9347-8","article-title":"Natural and synthetic polymers as inhibitors of drug efflux pumps","volume":"25","author":"Werle","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib9","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1023\/A:1015000503629","article-title":"Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS)","volume":"16","author":"Dintaman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib11","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/j.biomaterials.2011.03.005","article-title":"The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles","volume":"32","author":"Mo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/mp400340k","article-title":"Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance","volume":"11","author":"Jin","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib13","first-page":"2849","article-title":"Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein","volume":"9","author":"Kemper","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945011795378540","article-title":"Improving cancer chemotherapy with modulators of ABC drug transporters","volume":"12","author":"Shukla","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib16","first-page":"3651","article-title":"Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells","volume":"32","author":"Yellepeddi","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib17","doi-asserted-by":"crossref","first-page":"e112132","DOI":"10.1371\/journal.pone.0112132","article-title":"The reversal effects of 3-bromopyruvate on multidrug eesistance in\u00a0vitro and in\u00a0vivo derived from human breast MCF-7\/ADR cells","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib18","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1202625","article-title":"Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore","volume":"18","author":"Ravagnan","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib19","first-page":"6587","article-title":"Phase I trial of lonidamine with whole body hyperthermia in advanced cancer","volume":"48","author":"Robins","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-6632.1993.tb17225.x","article-title":"The role of lonidamine in the treatment of breast cancer patients","volume":"698","author":"Rosso","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1358\/dot.2003.39.3.799451","article-title":"Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors","volume":"39","author":"Di Cosimo","year":"2003","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.addr.2013.09.001","article-title":"Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities","volume":"65","author":"Kirtane","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3264","article-title":"Killing a cancer: what are the alternatives?","volume":"12","author":"Kreuzaler","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2012.10.003","article-title":"Advanced materials and processing for drug delivery: the past and the future","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/nnm.10.35","article-title":"Nanomedicinal strategies to treat multidrug-resistant tumors: current progress","volume":"5","author":"Dong","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrm2755","article-title":"Pathways and mechanisms of endocytic recycling","volume":"10","author":"Grant","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2217\/nnm.14.62","article-title":"Recent progress in multidrug delivery to cancer cells by liposomes","volume":"9","author":"Mo","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib31","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1016\/j.biomaterials.2012.01.036","article-title":"Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots","volume":"33","author":"Muthu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib32","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1016\/j.biomaterials.2013.01.055","article-title":"Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/bc700416u","article-title":"Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery","volume":"19","author":"Obata","year":"2008","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.mam.2007.02.003","article-title":"Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria","volume":"28","author":"Neuzil","year":"2007","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib35","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/adfm.201303222","article-title":"Gel\u2013liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy","volume":"24","author":"Jiang","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<327::AID-IJC4>3.0.CO;2-1","article-title":"Increased hyaluronidase levels in breast tumor metastases","volume":"73","author":"Bertrand","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib37","doi-asserted-by":"crossref","first-page":"9246","DOI":"10.1016\/j.biomaterials.2012.09.027","article-title":"Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery","volume":"33","author":"Jiang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib38","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/adma.201201498","article-title":"Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery","volume":"24","author":"Mo","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp1002653","article-title":"Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel\/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells","volume":"8","author":"Milane","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib41","first-page":"780","article-title":"Lonidamine as a modulator of alkylating agent activity in\u00a0vitro and in\u00a0vivo","volume":"51","author":"Teicher","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib42","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.biomaterials.2013.01.030","article-title":"Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids","volume":"34","author":"Mo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib43","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/srep02474","article-title":"Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3\u03b2","volume":"3","author":"Takahashi","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib44","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1038\/cddis.2012.93","article-title":"Non-small cell lung cancer stem\/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity","volume":"3","author":"Akunuru","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/bjc.2013.809","article-title":"CD44 targets Na+\/H+ exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1\/2","volume":"110","author":"Chang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nprot.2006.478","article-title":"Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts","volume":"2","author":"Frezza","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib47","doi-asserted-by":"crossref","first-page":"257108","DOI":"10.1155\/2013\/257108","article-title":"In\u00a0vitro morphological assessment of apoptosis induced by antiproliferative constituents from the rhizomes of curcuma zedoaria","volume":"2013","author":"Syed Abdul Rahman","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib48","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/mp300350e","article-title":"Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhances therapeutic efficacy: a novel application in pediatric nanomedicine","volume":"10","author":"Krishnan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib49","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/ncomms4364","article-title":"ATP-triggered anticancer drug delivery","volume":"5","author":"Mo","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib50","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.biomaterials.2010.11.010","article-title":"PEGylation of hyaluronic acid nanoparticles improves tumor targetability in\u00a0vivo","volume":"32","author":"Choi","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2015.09.022_bib51","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.M800886200","article-title":"The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization","volume":"283","author":"Pandey","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib52","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1021\/jacs.5b01435","article-title":"A\u00a0collaborative assembly strategy for tumor-targeted siRNA delivery","volume":"137","author":"Sun","year":"2015","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib53","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1158\/1535-7163.MCT-06-0118","article-title":"Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice","volume":"5","author":"Mayer","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biomaterials.2015.09.022_bib54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/1078-0432.CCR-08-0515","article-title":"Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors","volume":"15","author":"Batist","year":"2009","journal-title":"Clin. Cancer Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121500767X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121500767X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:13:20Z","timestamp":1758903200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121500767X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":54,"alternative-id":["S014296121500767X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.09.022","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}